-
Markets News, Oct. 30, 2025: Major Indexes Close Sharply Lower as Tech Stocks Slide; Meta, Microsoft Drop After Earnings
31 Oct 2025 01:25 GMT
… or buyout agreement. The biotech firm has faced pressure … 17% advance.
TradingView
Chipotle Stock Sinks on Comparable-Restaurant … intelligence has propelled stocks to record highs this … of an increasingly concentrated stock market. And the benchmark …
-
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges
30 Oct 2025 21:14 GMT
… costs piled up, while a biotech name benefited from reports of … .3%. Chipotle Mexican Grill (CMG) stock fell 18.2%, the most … partnership or buyout agreement. The biotech firm has faced pressure as …
-
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
30 Oct 2025 20:40 GMT
… public offering of its common stock. All of the shares … of common stock are being offered by … the shares of its common stock offered in the public … KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH CLINICAL …
-
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
30 Oct 2025 18:12 GMT
… ticket.
The New York-based biotech is at the centre of … and ARCH Venture Partners, the biotech venture giant led by Bob … the top of Europe’s stock market and was worth about …
-
PDS Biotechnology Stock Logs Best Session In 2 Months After FDA Fast-Track Push For Cancer Drug — Retail Bets On Early Approval
30 Oct 2025 09:29 GMT
… submission.
Retail traders on Stocktwits flooded discussions with optimism … .
Shares of PDS Biotechnology logged their best session … cancer.
On Stocktwits, retail sentiment for PDS Biotechnology was ‘ … saving therapy.
PDS Biotechnology’s stock has declined 38% …
-
Chipotle drags fast casual stocks lower, Meta reports raising $125B
30 Oct 2025 17:27 GMT
… bidding war with Pfizer over biotech firm Metcera. Novo offered to … the best and worst performing stocks of the trading session.
-
Novo makes bombshell $6.5B counteroffer to Pfizer's acquisition of obesity biotech Metsera
30 Oct 2025 15:53 GMT
… U.S. pharma for obesity biotech Metsera.
Until this morning, … could support monthly dosing. The biotech’s clinical-phase pipeline also … could buy 100% of the biotech’s equity.
“The Pfizer … immediate value for Metsera’s stockholders and ensures Metsera’s …
-
MLTX DEADLINE REMINDER: MoonLake Immunotherapeutics Sued for Securities Fraud after 90% Stock Drop -- Contact BFA Law by December 15 Class Action Deadline
30 Oct 2025 12:46 GMT
… of investors in MoonLake common stock. The case is pending … MoonLake is a clinical-stage biotechnology company focused on developing therapies … and commercial viability. The Stock Declines as the Truth Is … news, the price of MoonLake stock fell $55.75 per …
-
GM, Ford, Stellantis Supplier Vaults Into Top 10% Momentum Stocks — Breakout Ahead?
30 Oct 2025 12:31 GMT
… to the latest Benzinga Edge Stock Rankings‘ momentum percentile report … NVDA) leveraged ETFs, and biotech breakout names.
What Does Momentum … ranked measure of a stock';s relative price … top quartiles — the stock now combines defensive fundamentals with …
-
Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan
30 Oct 2025 10:50 GMT
… to its existing limited duration stockholder rights plan (as amended, … means without appropriately compensating all stockholders or without providing the Board … competition from other pharmaceutical and biotechnology companies and competition from generic …
About
© 1995-2025